Chemotherapy less likely to benefit older patients with breast cancer
the ONA take:
Examining data from Surveillance, Epidemiology and End Results (SEER) database, researchers from The University of Texas Health Science Center at Houston (UTHealth) found that chemotherapy does not improve survival for older women with breast cancer.
SEER database provided information on 14,440 women with stage I to IIIA hormone receptor-negative breast cancer and 26,893 men and women with stage III colon cancer. All diagnoses were made between 1992 and 2009, and all patients were older than 65 years.
Risk of death from all causes decreased by age among the women who had breast cancer (30% for women ages 65 to 69 years; 26% for ages 70 to 74 years; 24% for ages 75 to 79). The risk of mortality was not significantly reduced for women older than 80 years.
However, this trend was not seen among men and women with colon cancer. Chemotherapy remained effective for these patients until age 89 years.
The investigators noted that previous research showed that chemotherapy is inefficient in patients older than 70 years with breast cancer, but the sample sizes were small. The larger sample size used in this study provides strong evidence to support this finding.
Chemotherapy does not improve survival for older women with breast cancer.
- Novel Colonoscopy Prep Is Poised to Improve Screening Rates for Colon Cancer
- Short-Term Intervention May Have Long-term Diet Effect in Hispanic Breast Cancer Survivors
- How Physical Changes From Breast Cancer Affect Self-Image: Considerations for Clinicians
- Childhood Cancer Linked to Poor Diet Quality in Adult Survivors
- Low-Dose Sublingual Fentanyl Safe, Effective in Patients Receiving Lower Opioid Doses
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Study Suggests More Men With Prostate Cancer Would Choose Active Surveillance if it Were Offered
- The Bounty of Failure: A Well-Versed Nursing Experience
- Olaratumab in Combo With Doxorubicin Approved for Soft Tissue Sarcoma
- POLST Programs Can Benefit from the Relationship Between Patients and Nurse Practitioners
- Hydroxyurea May Improve Kidney Function in PV-Associated Nephrotic Syndrome
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|